This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: The University of Chicago, Other. Active years: 2002-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2002-2024
Title: Innovations by Steven J Chmura
Introduction
Steven J Chmura is an accomplished inventor based in Chicago, IL. He holds two patents that contribute significantly to the field of medical technology, particularly in cancer treatment. His innovative approaches have the potential to enhance the effectiveness of radiotherapy and cancer therapies.
Latest Patents
One of his latest patents is titled "System and method for multi-site radiotherapy." This invention provides a method for radiating multiple masses in a patient by utilizing a three-dimensional model that includes the locations of various organs at risk (OARs) and the prescribed radiation dosages for the masses. The method involves computing a candidate set of beams with specific paths that travel through the masses, scoring these beams based on the dosages provided, and selecting the best-scoring beams for treatment. Another notable patent is "Chelerythrine-based therapies for cancer," which highlights the effectiveness of Chelerythrine as an inhibitor of solid tumor growth. This compound is particularly potent when combined with chemotherapeutic agents that damage DNA.
Career Highlights
Throughout his career, Steven has worked with prestigious institutions, including the University of Chicago. His contributions to the field of oncology have been recognized and have paved the way for advancements in cancer treatment methodologies.
Collaborations
Steven has collaborated with notable professionals in his field, including Ralph R Weichselbaum and Donald W Kufe. These collaborations have further enriched his research and innovations.
Conclusion
Steven J Chmura's work exemplifies the intersection of innovation and medical science. His patents reflect a commitment to improving cancer treatment and enhancing patient outcomes. His contributions are invaluable to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile